du Mesnil de Rochemont R, Berkefeld J, Buchkremer M, Arndt H, Neumann-Haefelin T, Singer O, Steinmetz H, Zanella F, Sitzer M
Institut für Neuroradiologie, Universität Frankfurt.
Rofo. 2006 Jan;178(1):96-102. doi: 10.1055/s-2005-858635.
Recurrent ischemic symptoms attributable to intracranial high-grade vertebrobasilar artery stenoses are associated with a high risk of ischemic stroke, particularly if these occur in spite of aggressive medical treatment. Long term efficacy data for endovascular stent angioplasty of symptomatic intracranial stenoses are lacking. The purpose of this prospective study is to determine the rates of deaths, of ischemic events and of restenosis during long-term follow-up.
Between June 2001 and February 2004 twelve patients (11 male, 1 female; median 63 yrs; range, 46 - 75 yrs) with recurrent ischemic symptoms attributed to > or = 70 % intracranial vertebro-basilar artery stenoses, who had failed aggressive medical treatment, were included. Median follow-up was 24 months (range: 6 to 36 months). Intracranial stenoses were measured using 3D rotation angiography data sets and treated with balloon expandable stents. All patients were scheduled for follow-up including clinical (Barthel Index) and transcranial Doppler examinations and intraarterial angiography at 6 months after intervention. Clinical outcome was defined as the rate of stroke in any vascular territory or death during follow-up. Vascular outcome was determined by the rate of in-stent restenosis 50 % on follow-up as examined by intraarterial angiography at 6 months or by transcranial color-coded duplex sonography.
Stent placement was technically successful in all patients. No patient had further cerebral ischemic symptoms; two patients died (1 myocardial infarct, 1 sudden death) during follow-up of median 24 months. The degree of stenoses was reduced from median 81 % (range 69 - 94 %) to 19 % (range 10 - 36 %) immediately after stent placement and to 32 % (range 22 - 48 %) after 6 months. No restenosis > or = 50 % occurred during follow-up.
Based on this limited series, we believe that in patients, with recurrent symptoms despite aggressive medical treatment, endovascular stent placement in intracranial high-grade vertebrobasilar artery stenoses can be an effective and safe treatment option.
颅内高级别椎基底动脉狭窄所致的复发性缺血症状与缺血性卒中的高风险相关,尤其是在积极药物治疗后仍出现这些症状时。目前缺乏症状性颅内狭窄血管内支架血管成形术的长期疗效数据。这项前瞻性研究的目的是确定长期随访期间的死亡率、缺血事件发生率和再狭窄率。
2001年6月至2004年2月期间,纳入了12例(11例男性,1例女性;中位年龄63岁;范围46 - 75岁)因颅内椎基底动脉狭窄≥70%而出现复发性缺血症状且积极药物治疗无效的患者。中位随访时间为24个月(范围:6至36个月)。使用三维旋转血管造影数据集测量颅内狭窄,并采用球囊扩张支架进行治疗。所有患者均安排了随访,包括临床(Barthel指数)和经颅多普勒检查,以及干预后6个月的动脉内血管造影。临床结局定义为随访期间任何血管区域的卒中发生率或死亡率。血管结局通过随访时支架内再狭窄率≥50%来确定,这是在6个月时通过动脉内血管造影或经颅彩色编码双功超声检查得出的。
所有患者的支架置入在技术上均获成功。中位随访24个月期间,无患者出现进一步的脑缺血症状;2例患者死亡(1例心肌梗死,1例猝死)。支架置入后,狭窄程度立即从中位81%(范围69 - 94%)降至19%(范围10 - 36%),6个月后降至32%(范围22 - 48%)。随访期间未出现≥50%的再狭窄。
基于这个有限的系列研究,我们认为,对于尽管接受了积极药物治疗仍有复发性症状的患者,颅内高级别椎基底动脉狭窄的血管内支架置入术可能是一种有效且安全的治疗选择。